Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug discovery: some directional pointers

D E Clarke

    Trends in Pharmacological Sciences
    |January 1, 1997
    PubMed
    Summary
    This summary is machine-generated.

    This article argues for prioritizing scientists over managers in pharmaceutical drug discovery decision-making. It proposes a new operational scheme to empower scientific expertise and streamline the drug development process.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effectiveness of a vegetable dental chew on periodontal disease parameters in toy breed dogs.

    Journal of veterinary dentistry·2012
    Same author

    The Brøset Violence Checklist: clinical utility in a secure psychiatric intensive care setting.

    Journal of psychiatric and mental health nursing·2010
    Same author

    Seasonal allergies and suicidality: results from the National Comorbidity Survey Replication.

    Acta psychiatrica Scandinavica·2009
    Same author

    Ethnicity and mental health: conceptualization, definition and operationalization of ethnicity from a Canadian context.

    Chronic diseases in Canada·2008
    Same author

    Pathways to suicidality across ethnic groups in Canadian adults: the possible role of social stress.

    Psychological medicine·2007
    Same author

    Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.

    Bioorganic & medicinal chemistry letters·2003
    Same journal

    Targeting developmental reprogramming: hPSC insights for cancer interception.

    Trends in pharmacological sciences·2026
    Same journal

    July 2026 issue first authors.

    Trends in pharmacological sciences·2026
    Same journal

    Chronobiomaterials for circadian-aligned brain therapeutics.

    Trends in pharmacological sciences·2026
    Same journal

    Biosensors for translatable GPCR bias.

    Trends in pharmacological sciences·2026
    Same journal

    ECM stiffness and epigenetics in organ fibrosis.

    Trends in pharmacological sciences·2026
    Same journal

    Which HTT transcript to lower?

    Trends in pharmacological sciences·2026
    See all related articles

    Area of Science:

    • Pharmaceutical industry
    • Drug discovery and development
    • Management science

    Background:

    • The pharmaceutical industry extensively discusses management's role in drug discovery.
    • Current management practices may not optimally leverage scientific expertise.
    • There is a need to re-evaluate decision-making structures in drug discovery programs.

    Purpose of the Study:

    • To present personal views on management's influence in pharmaceutical drug discovery.
    • To de-emphasize the role of managers in programmatic scientific decision-making.
    • To propose an operational scheme for reorganizing drug discovery management.

    Main Methods:

    • Qualitative analysis of management's role in scientific decision-making.
    • Conceptual framework development for organizational restructuring.

    Related Experiment Videos

  • Literature review on management theories in scientific research.

    • Main Results:

    • Personal perspective advocating for scientist-led decision-making.
    • Reduced emphasis on managerial influence in programmatic choices.
    • A proposed operational scheme for organizational reform.

    Conclusions:

    • Empowering scientists is crucial for effective drug discovery.
    • Reorganization can enhance the efficiency of pharmaceutical R&D.
    • A shift in management philosophy is needed to foster innovation.